A serous borderline ovarian tumour in a transgender male adolescent

Here we present a transgender male adolescent with an androgen receptor-positive serous borderline ovarian tumour in the setting of testosterone treatment for medical gender transition. To our knowledge, this is the second report of borderline tumour in a transgender individual and the first in an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Millington, Kate, Hayes, Katherine, Pilcher, Sarah, Roberts, Stephanie, Vargas, Sara O., French, Amanda, Veneris, Jennifer, O’Neill, Allison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851115/
https://www.ncbi.nlm.nih.gov/pubmed/33106582
http://dx.doi.org/10.1038/s41416-020-01129-4
_version_ 1783645577449308160
author Millington, Kate
Hayes, Katherine
Pilcher, Sarah
Roberts, Stephanie
Vargas, Sara O.
French, Amanda
Veneris, Jennifer
O’Neill, Allison
author_facet Millington, Kate
Hayes, Katherine
Pilcher, Sarah
Roberts, Stephanie
Vargas, Sara O.
French, Amanda
Veneris, Jennifer
O’Neill, Allison
author_sort Millington, Kate
collection PubMed
description Here we present a transgender male adolescent with an androgen receptor-positive serous borderline ovarian tumour in the setting of testosterone treatment for medical gender transition. To our knowledge, this is the second report of borderline tumour in a transgender individual and the first in an adolescent, an age group in which borderline tumours are extremely rare. We discuss the specific considerations of treating ovarian tumours in the transgender male population, the incompletely understood role of androgens in the genesis of ovarian epithelial neoplasia, and an emphasis on assessing cancer risk in transgender patients based on patient anatomy.
format Online
Article
Text
id pubmed-7851115
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78511152021-10-27 A serous borderline ovarian tumour in a transgender male adolescent Millington, Kate Hayes, Katherine Pilcher, Sarah Roberts, Stephanie Vargas, Sara O. French, Amanda Veneris, Jennifer O’Neill, Allison Br J Cancer Brief Communication Here we present a transgender male adolescent with an androgen receptor-positive serous borderline ovarian tumour in the setting of testosterone treatment for medical gender transition. To our knowledge, this is the second report of borderline tumour in a transgender individual and the first in an adolescent, an age group in which borderline tumours are extremely rare. We discuss the specific considerations of treating ovarian tumours in the transgender male population, the incompletely understood role of androgens in the genesis of ovarian epithelial neoplasia, and an emphasis on assessing cancer risk in transgender patients based on patient anatomy. Nature Publishing Group UK 2020-10-27 2021-02-02 /pmc/articles/PMC7851115/ /pubmed/33106582 http://dx.doi.org/10.1038/s41416-020-01129-4 Text en © Cancer Research UK 2020 https://creativecommons.org/licenses/by/4.0/ Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
spellingShingle Brief Communication
Millington, Kate
Hayes, Katherine
Pilcher, Sarah
Roberts, Stephanie
Vargas, Sara O.
French, Amanda
Veneris, Jennifer
O’Neill, Allison
A serous borderline ovarian tumour in a transgender male adolescent
title A serous borderline ovarian tumour in a transgender male adolescent
title_full A serous borderline ovarian tumour in a transgender male adolescent
title_fullStr A serous borderline ovarian tumour in a transgender male adolescent
title_full_unstemmed A serous borderline ovarian tumour in a transgender male adolescent
title_short A serous borderline ovarian tumour in a transgender male adolescent
title_sort serous borderline ovarian tumour in a transgender male adolescent
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851115/
https://www.ncbi.nlm.nih.gov/pubmed/33106582
http://dx.doi.org/10.1038/s41416-020-01129-4
work_keys_str_mv AT millingtonkate aserousborderlineovariantumourinatransgendermaleadolescent
AT hayeskatherine aserousborderlineovariantumourinatransgendermaleadolescent
AT pilchersarah aserousborderlineovariantumourinatransgendermaleadolescent
AT robertsstephanie aserousborderlineovariantumourinatransgendermaleadolescent
AT vargassarao aserousborderlineovariantumourinatransgendermaleadolescent
AT frenchamanda aserousborderlineovariantumourinatransgendermaleadolescent
AT venerisjennifer aserousborderlineovariantumourinatransgendermaleadolescent
AT oneillallison aserousborderlineovariantumourinatransgendermaleadolescent
AT millingtonkate serousborderlineovariantumourinatransgendermaleadolescent
AT hayeskatherine serousborderlineovariantumourinatransgendermaleadolescent
AT pilchersarah serousborderlineovariantumourinatransgendermaleadolescent
AT robertsstephanie serousborderlineovariantumourinatransgendermaleadolescent
AT vargassarao serousborderlineovariantumourinatransgendermaleadolescent
AT frenchamanda serousborderlineovariantumourinatransgendermaleadolescent
AT venerisjennifer serousborderlineovariantumourinatransgendermaleadolescent
AT oneillallison serousborderlineovariantumourinatransgendermaleadolescent

Ejemplares similares